Showing 7791-7800 of 20882 results for "".
- City of Hope, TGen Researchers Develop Machine-Learning Tool to Detect Cancer Earlier via Liquid Biopsyhttps://reachmd.com/news/city-of-hope-tgen-researchers-develop-machine-learning-tool-to-detect-cancer-earlier-via-liquid-biopsy/2456963/The innovative “fragmentomics” approach could one day allow doctors to identify cancer in patients sooner than possible today using smaller blood draws CONTACTZen LogsdonCity of Hope626-409-9367
- Cancer Vaccine with Minimal Side Effects Nearing Phase 3 Clinical Trialshttps://reachmd.com/news/cancer-vaccine-with-minimal-side-effects-nearing-phase-3-clinical-trials/2456953/Dr. Thomas Wagner, founder of the biotech company Orbis Health Solutions and cancer researcher, has made it his life's mission to find a way to treat cancer without the dreaded side effects that, for some, can become worse than the cancer itself or may even lead to an earlier death.
- Minority Populations Largely Unrepresented in Gynecologic Cancer Clinical Trialshttps://reachmd.com/news/minority-populations-largely-unrepresented-in-gynecologic-cancer-clinical-trials/2456959/New research further revealed disparities in gynecologic cancer clinical trial enrollment, warranting increased efforts to improve representation in these trials. The cohort study was published in
- New Technology Allows Researchers to Track Brain Cells' 'Off Switches'https://reachmd.com/news/new-technology-allows-researchers-to-track-brain-cells-off-switches/2456919/Levels of phosphorylated PDH (green) drastically increased in mouse brains cells after the mice were anesthetized for two hours (on right), showing the inhibition of the neurons. Credit: Scripps Research Fo
- Paradigm Shift in Neurological Disease Understandinghttps://reachmd.com/news/paradigm-shift-in-neurological-disease-understanding/2456921/One of the things that makes developing effective treatments for Parkinson's disease so challenging is its complexity. While some forms are caused by genetics, others have environmental factors, and patients can show a wide range of symptoms of varying severity. Diagnosis of Par
- New Therapeutic Approach for the Treatment of Sarcoidosishttps://reachmd.com/news/new-therapeutic-approach-for-the-treatment-of-sarcoidosis/2456923/New therapeutic approach for the treatment of sarcoidosis - A research team led by Georg Stary (Medical University of Vienna and CeMM) has identified a new approach to treating the inflammatory disease sarcoidosis. In a clinical study, the in
- Long-Term Follow Up Pinpoints Side Effects of Treatments for Prostate Cancer Patientshttps://reachmd.com/news/long-term-follow-up-pinpoints-side-effects-of-treatments-for-prostate-cancer-patients/2456927/A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population. The CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation for
- APOE Genetic Variants Linked to Alzheimer's Disease Are Also Associated with the Development of Subclinical Atherosclerosishttps://reachmd.com/news/apoe-genetic-variants-linked-to-alzheimers-disease-are-also-associated-with-the-development-of-subclinical-atherosclerosis/2456928/Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid have found that one of the most potent genetic risk factors for Alzheimer disease, apolipoprotein E4 (APOE4), is also associated with an increased risk of developing subclinical atheroscl
- CT-Based Radiomics Deep Learning to Predict Lymph Node Metastasis in Tumorshttps://reachmd.com/news/ct-based-radiomics-deep-learning-to-predict-lymph-node-metastasis-in-tumors/2456920/Schematic representation of the study's design and procedural steps. (A) Segmentation was conducted on atrial phase CT images. (B) Radiomics and deep learning features were extracted separately. (C) Feature selection was based on the U-test, ICC, and
- Scientists Make COVID Receptor Protein in Mouse Cellshttps://reachmd.com/news/scientists-make-covid-receptor-protein-in-mouse-cells/2456925/Scientists Make COVID Receptor Protein in Mouse Cells Initially motivated to make receptor-based sensors and therapies for COVID-19, scientists develop general strategy for producing other complex proteins January 22, 2024